Authors:
Gordon, J
Challa, A
Levens, JM
Gregory, CD
Williams, JM
Armitage, RJ
Cook, JP
Roberts, LM
Lord, JM
Citation: J. Gordon et al., CD40 ligand, Bcl-2, and Bcl-x(L) spare group I Burkitt lymphoma cells fromCD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin, CELL DEAT D, 7(9), 2000, pp. 785-794
Authors:
Pound, JD
Challa, A
Holder, MJ
Armitage, RJ
Dower, SK
Fanslow, WC
Kikutani, H
Paulie, S
Gregory, CD
Gordon, J
Citation: Jd. Pound et al., Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells, INT IMMUNOL, 11(1), 1999, pp. 11-20
Authors:
Challa, A
Pound, JD
Armitage, RJ
Gordon, J
Citation: A. Challa et al., Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis inhuman B cells, ALLERGY, 54(6), 1999, pp. 576-583
Citation: Ae. Morris et al., Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154), J BIOL CHEM, 274(1), 1999, pp. 418-423
Authors:
Kubin, MZ
Parshley, DL
Din, W
Waugh, JY
Davis-Smith, T
Smith, CA
Macduff, BM
Armitage, RJ
Chin, W
Cassiano, L
Borges, L
Petersen, M
Trinchieri, G
Goodwin, RG
Citation: Mz. Kubin et al., Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48, EUR J IMMUN, 29(11), 1999, pp. 3466-3477